AdAlta Limited (1AD) is a clinical stage biotechnology company and is involved in the discovery and development of next generation cell and protein-based therapeutics.
Find out what a historical investment in Adalta Call 0.01 AUD Adalta 28May2028 Opt Def would be worth today using our 1ADO stock calculator.
Buying 1ADO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Adalta Call 0.01 AUD Adalta 28May2028 Opt Def in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in 1ADO
What is the ticker symbol of Adalta Call 0.01 AUD Adalta 28May2028 Opt Def?
The ticker symbol for Adalta Call 0.01 AUD Adalta 28May2028 Opt Def is 1ADO.
How much is one share of 1ADO?
One share of 1ADO is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of Adalta Call 0.01 AUD Adalta 28May2028 Opt Def 1ADO?
As of 20 November 2026 Adalta Call 0.01 AUD Adalta 28May2028 Opt Def has a market cap of $6.42M.
What is the P/E ratio of 1ADO?
The Price to Earnings ratio of 1ADO is -0.43.
What is the Earnings Per Share of 1ADO?
The Earnings Per Share of 1ADO is -$0.00.
What is the 52-week high for Adalta Call 0.01 AUD Adalta 28May2028 Opt Def stock?
The Adalta Call 0.01 AUD Adalta 28May2028 Opt Def 52-week high stock price is $0.00.
What is the 52-week low for Adalta Call 0.01 AUD Adalta 28May2028 Opt Def stock?
The Adalta Call 0.01 AUD Adalta 28May2028 Opt Def 52-week low stock price is $0.00.
Can I buy 1ADO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy 1ADO shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.